Nonvalvular atrial fibrillation - Globe Thesis

Keyword [Nonvalvular atrial fibrillation] Result: 101 - 120 \| Page: 6 of 7
101.	Safety And Efficacy Analysis Of Warfarin Precision Anticoagulant Therapy In Patients With Nonvalvular Atrial Fibrillation
102.	The Risk Factors Analysis Of Left Atrial Thrombosis And The Exploration Of Risk Assessment Model In Patients With Nonvalvular Atrial Fibrillation
103.	The Observational Study Of Dabigatran In Anticoagulation After Radiofrequency Catheter Ablation Of Nonvalvular Atrial Fibrillation
104.	The Role CCTA In The Study Of The Mechanism Of Secondary Changes In Left Atrial Appendage And Its Predictive Value For Cardiogenic Stroke Risk
105.	Establishment And Comparison Of Risk Prediction Models For Patients With Nonvalvular Atrial Fibrillation And Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention
106.	Study On Cognitive Function Changes And Influencing Factors In Patients With Nonvalvular Atrial Fibrillation
107.	Effect Of Different Therapeutic Methods On Prevention Of Ischemic Events In Nonvalvular Atrial Fibrillation
108.	A Single-center Retrospective Analysis Of The Safety And Efficacy Of LAAO In Patients With Nonvalvular Atrial Fibrillation
109.	Study On Correlation Between Coagulation Function And Bleeding Events In Patients With Nonvalvular Atrial Fibrillation Treated With Dabigatran
110.	Effect Of Left Atrial Appendage Occlusion On Left Ventricular Function In Patients With Non-valvular Atrial Fibrillation
111.	Effect Of Essential Hypertension On Nonvalvular Atrial Fibrillation
112.	Risk Analysis Of NT-proBNP And D-dimer Combined With LAD For Predicting Ischemic Stroke In Patients With Nonvalvular Atrial Fibrillation
113.	Analysis Of Status Of Anticoagulant Therapy For Nonvalvular Atrial Fibrillation And Risk Factors For Recurrence Of Radiofrequency Ablation
114.	Predictors Of Left Atrial Appendage Occluder Related Thrombosis:A Meta-Analysis
115.	Analysis Of Risk Factors For Left Atrial Appendage Thrombosis Among Patients With Non-valvular Atrial Fibrillation
116.	Effect Of Pharmacologic Cardioversion And Radiofrequency Ablation On Patients With Nonvalvular Atrial Fibrillation Complicated With Pulmonary Hypertension
117.	Study On The Management Status Of Hospitalized Elderly Patients With Non-valvular Atrial Fibrillation In Dali
118.	Comparison Of Novel Oral Anticoagulants Rivaroxaban And Dabigatran Versus Warfarin In Patients With Nonvalvular Atrial Fibrillation With High Bleeding Risk
119.	Correlation Between Gut Microbiota And Bleeding After Anticoagulation In Patients With Nonvalvular Atrial Fibrillation
120.	Efficacy And Safety Of Apixaban And Warfarin In Prevention Of Ischemic Stroke: A Systematic Review And Meta-Analysis
<<First <Prev Next> Last>> Jump to